News
Turning Crisis into Strategy: Contracts, projects and disputes at a global chokepoint
Turning Crisis into Strategy: Contracts, projects and disputes at a global chokepoint
We will highlight key areas that the IP function at a pharma or biotech company of any size should consider, including strategies for investments in IP/innovation, license agreement strategies, patent prosecution considerations, what rights to prioritize (and not), litigation strategies, and more.